Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Doxepin hydrochloride
Cat. No.:
OB0225LY-0133
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Doxepin hydrochloride is a tricyclic antidepressant with antihistamine activity.
Synonym:
Toruan; Doxepin HCl; Aponal; Novoxapin; 1229-29-4; 11-(3-Dimethylamino-propyliden)-6,11-dihydro-dibenz(b,e)oxipin
CAS No.:
1229-29-4
Compound CID:
667477
Formula:
C19H22ClNO
Formula Weight:
315.837
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Doxepin hydrochloride can be used to modulate the antagonism of histamine H(1) and H(2) receptors.
Library Information
Targets:
Monoamine transporters; G protein-coupled receptors (GPCRs)
Receptors:
5-HT receptor; Adrenergic receptor; Cytochrome P450; Dopamine receptor; Histamine H1 receptor; mAChR; Noradrenaline transporter (Sodium-dependent); Sert (Sodium-dependent)
Pathways:
Metabolism; Neuronal signaling; Immunology/Inflammation; GPCR/G protein
Plate Number:
AOCL-2
Plate Location:
f6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
60 mg/mL; 189.97 mM
